Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.
The European Medicines Agency (EMA) has confirmed its recommendation to suspend a number of...
Authorities raided medical clinics, pharmacies and other locations across the South on Wednesday...
The U.S. Food and Drug Administration (FDA) is warning health care professionals about the risk...
In recent weeks, the case of supplements containing an amphetamine-like substance called BMPEA has prompted FDA recalls; industry trade group condemnation; appeals from Congress for increased enforcement, consumer education campaigns and greater participation by ...
Sponsors seeking EU authorization to market fixed-dose drug combinations should conduct multiarm, randomized, controlled trials comparing the FDC with its individual components, the European Medicines Agency says.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has amended a previously granted Breakthrough Therapy Designation for the investigational daclatasvir and sofosbuvir combination for use in hepatitis C (HCV) patients.
There’s a new treatment option for schizophrenia – INVEGA TRINZA (three-month paliperidone palmitate), the first and only schizophrenia medication to be administered just four times a year, providing the longest dosing interval available.
Eagle Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (“USPTO”) has granted U.S. Patent No. 9,034,908, which pertains to the use of the bendamustine hydrochloride (HCl) formulation administered in a 50mL bag within ten minutes.
The Ebola crisis in western Africa showed the world in a painful way that a global catastrophe plan is needed to deal with future epidemics, German Chancellor Angela Merkel said Monday. "The struggle (against Ebola) is only won if there are no new ...
Pfizer Inc. today announced that it has received a request for additional information from the FTC with respect to its previously announced proposed acquisition of Hospira.
Treatment results with the breast cancer drug Herceptin, as well as chemotherapy, did improve, but the drug's backers had been hoping to see better results.
U.S. District Court Judge Charles Breyer said the acts alleged by prosecutors do not fall under an exemption in federal drug law for transportation companies such as FedEx.
Beach dwellers in Alabama and North Carolina have stumbled upon bulky packages worth thousands of dollars.
Colombian President Santos last week decided to halt fumigation in the wake of a report by a research arm of the World Health Organization classifying (anti-coca) glyphosate as a probable carcinogen.
Attorneys for FedEx are set to appear in court, as they seek to dismiss a federal indictment that accuses the company of knowingly shipping illegal prescription drugs from two online pharmacies.
Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.
An independent panel of experts said Monday that "deep and substantial" change is needed at the WHO following its slow response to early warnings about West Africa's Ebola outbreak.
Saturday marked 42 days since Liberia's last Ebola case — the benchmark used to declare the outbreak over. The epidemic claimed more than 4,700 lives in the country.
The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator for the prevention of oral mucositis.
The Food and Drug Administration said in an online review that the benefit was small and it is unclear if the addition of a second drug ingredient adds to the pill's effectiveness.
For the first time, Ebola has been discovered inside the eyes of a patient months after the virus was gone from his blood.
A huge nationwide spike in hospitalizations last month was caused by a class of drugs often called synthetic marijuana, possibly illustrating the potency and dangers of the chemicals used to make them.
The growth in the insulin pump market is driven by the aging population, increasing incidence of diabetes, expanding global markets, new product innovations and increasing life expectancy.
Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets.
Teva announced a voluntary recall of eight lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter.
Dow Development Laboratories in California is working to position itself as the "go-to" contract manufacturer for topical product development services.
The FDA today approved Raplixa, the first spray-dried fibrin sealant approved by the agency. It is used to help control bleeding during surgery.
Tuzistra XR is an extended-release oral suspension combination of codeine and chlorpheniramine in treating coughs and upper respiratory allergies.
- Page 1